Suppr超能文献

基于大型癌症登记处的研究显示,术前 MRI 对乳腺癌手术有益。

Benefits of preoperative MRI in breast cancer surgery studied in a large population-based cancer registry.

机构信息

Departments of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Department of Research, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.

出版信息

Br J Surg. 2015 Dec;102(13):1649-57. doi: 10.1002/bjs.9947. Epub 2015 Oct 8.

Abstract

BACKGROUND

Although evidence for the benefits of preoperative MRI in breast cancer is lacking, use of MRI is increasing and characterized by large interhospital variation. The aim of the study was to evaluate MRI use and surgical outcomes retrospectively.

METHODS

Women with invasive breast cancer (pT1-3) or ductal carcinoma in situ (DCIS), diagnosed in 2011-2013, were selected from the Netherlands Cancer Registry and subdivided into the following groups: invasive cancer, high-grade DCIS, non-palpable cancer, age 40 years or less, and invasive lobular cancer. Associations between preoperative MRI use and initial mastectomy, resection margin after breast-conserving surgery (BCS), re-excision after BCS, and final mastectomy were analysed.

RESULTS

In total, 5514 women were included in the study; 1637 (34·1 per cent) of 4801 women with invasive cancer and 150 (21·0 per cent) of 713 with DCIS had preoperative MRI. Positive resection margins were found in 18·1 per cent women who had MRI and in 15·1 per cent of those who did not (adjusted odds ratio (OR) 1·20, 95 per cent c.i. 1·00 to 1·45), with no differences in subgroups. Re-excision rates were 9·8 per cent in the MRI group and 7·2 per cent in the no-MRI group (adjusted OR 1·33, 1·04 to 1·70), with no differences in subgroups. In the MRI group, 38·8 per cent of patients ultimately underwent mastectomy, compared with 24·2 per cent in the no-MRI group (adjusted OR 2·13, 1·87 to 2·41). This difference was not found for patients aged 40 years or less, or for those diagnosed with lobular cancer.

CONCLUSION

No subgroup was identified in which preoperative MRI influenced the risk of margin involvement or re-excision rate after BCS. MRI was significantly associated with more extensive surgery, except in patients aged 40 years or less and those with invasive lobular cancer. These results suggest that use of preoperative MRI should be more targeted, and that general, widespread use be discouraged.

摘要

背景

尽管术前 MRI 在乳腺癌中的益处证据不足,但 MRI 的使用正在增加,并表现出医院间的巨大差异。本研究旨在回顾性评估 MRI 的使用情况和手术结果。

方法

从荷兰癌症登记处选择了 2011-2013 年间诊断为浸润性乳腺癌(pT1-3)或导管原位癌(DCIS)的女性,并将其分为以下几组:浸润性癌、高级别 DCIS、不可触及的癌症、年龄 40 岁或以下、浸润性小叶癌。分析了术前 MRI 使用与初始乳房切除术、保乳手术后(BCS)切缘、BCS 后再次切除术和最终乳房切除术之间的关系。

结果

共纳入 5514 名女性;4801 名浸润性癌女性中有 1637 名(34.1%)和 713 名 DCIS 中有 150 名(21.0%)进行了术前 MRI。MRI 组的阳性切缘率为 18.1%,而未行 MRI 组的阳性切缘率为 15.1%(调整后的优势比(OR)为 1.20,95%置信区间(CI)为 1.00 至 1.45),亚组间无差异。MRI 组的再次切除率为 9.8%,而未行 MRI 组的再次切除率为 7.2%(调整后的 OR 为 1.33,1.04 至 1.70),亚组间也无差异。在 MRI 组中,最终接受乳房切除术的患者比例为 38.8%,而未行 MRI 组的比例为 24.2%(调整后的 OR 为 2.13,1.87 至 2.41)。这一差异在 40 岁或以下的患者或浸润性小叶癌患者中并未发现。

结论

没有发现术前 MRI 影响切缘受累风险或 BCS 后再次切除率的亚组。MRI 与更广泛的手术显著相关,但在 40 岁或以下的患者和浸润性小叶癌患者中并非如此。这些结果表明,术前 MRI 的使用应更有针对性,并应避免普遍广泛使用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验